查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451473

2024-2032 年按組件（軟體、服務）、部署類型（本地、基於雲端）、最終用戶（醫院、診所、門診服務中心、專科中心等）和區域分類的感染監控解決方案市場報告

Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球感染監測解決方案市場規模達到6.526億美元。展望未來， IMARC Group預計到2032年市場規模將達到13.148億美元，2024-2032年複合年成長率（CAGR）為7.65%。不斷成長的醫療保健相關感染 (HAI)、防止感染傳播的嚴格監管合規性以及允許自動捕獲患者資料的醫療保健 IT 的進步是推動該市場的一些主要因素。

感染監測解決方案是醫療機構用來監測和分析患者群體中感染的流行、傳播和影響的綜合系統。他們利用先進的資料收集、整合和分析工具來追蹤和報告各種醫療保健相關感染 (HAI)，例如血流感染、手術部位感染和呼吸道感染。由於它們使醫療保健提供者能夠及時識別潛在的疫情、實施有針對性的干涉措施並最終提高患者的安全，因此全球範圍內對感染監測解決方案的需求正在增加。

目前，對包括感染控制在內的患者安全的日益關注正在促進市場的成長。與此一致的是，人們越來越意識到醫療保健中數據驅動決策的重要性，這正在加強市場的成長。此外，老年人口對感染監測解決方案的需求不斷成長，因為他們更容易受到感染，這對市場產生了積極影響。此外，對監測和減輕傳染病爆發的監測解決方案的投資不斷增加，為行業投資者提供了利潤豐厚的成長機會。此外，資料分析、人工智慧 (AI) 和機器學習 (ML) 方面的創新正在增強感染監測解決方案的能力，並使其更加高效，從而支持市場的成長。除此之外，全球醫療保健基礎設施的改善正在促進市場的成長。

感染監測解決方案市場趨勢/促進因素：

醫療保健相關感染 (HAI) 不斷上升

由於個人中與醫療相關的感染 (HAI) 不斷增加，感染監測解決方案的採用率不斷上升，推動了市場的成長。與此一致的是，這些感染對患者的健康造成威脅，導致住院時間延長、醫療費用增加，在某些情況下甚至導致死亡。除此之外，減輕這些感染以提高病人安全的需求也在增加。透過持續監測和分析患者資料，這些解決方案能夠及早發現感染，並使醫療機構能夠及時實施干預措施。因此，醫院感染的減少不僅可以改善病患的治療效果，還可以為醫療機構節省成本。

嚴格遵守法規以防止感染傳播

在醫療保健行業，遵守監管要求和認證標準至關重要。醫療保險和醫療補助服務中心 (CMS) 以及聯合委員會等監管機構正在強制報告和預防醫療保健相關感染 (HAI)。此外，不遵守規定可能會導致處罰和聲譽損害。除此之外，感染監測解決方案有助於確保合規性。它們有助於準確的資料收集、分析和感染率報告，幫助醫療機構有效滿足監管要求。此外，認證機構將感染控制視為醫療保健品質的重要組成部分。此外，醫療保健組織正在投資先進的感染監測系統，這些系統不僅可以滿足監管需求，還有助於實現和維持認證，提高其聲譽和可信度。

醫療保健 IT 的進步

電子健康記錄（EHR）、健康資訊交換（HIE）和綜合健康系統的日益普及正在推動市場的成長。據此，感染監測解決方案可以與現有的醫療保健 IT 基礎設施無縫連接，並允許自動捕獲患者資料、實驗室結果和其他相關資訊。這些系統的介面簡化了監控過程，並確保了即時資料的可用性以進行分析，這提供了積極的市場前景。醫療保健專業人員可以快速獲得可行的見解，有助於及早發現和應對潛在的疫情爆發。此外，這些解決方案和醫療保健 IT 不僅可以增強感染控制，還有助於提高醫療保健服務的整體效率和有效性。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球感染監測解決方案市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按組成部分

  • 軟體
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依部署類型

  • 本地
    • 市場走向
    • 市場預測
  • 基於雲端
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測
  • 流動服務中心
    • 市場走向
    • 市場預測
  • 專科中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Centrak Inc. (Halma plc)
    • Cerner Corporation
    • CKM Healthcare Incorporated
    • Ecolab Inc.
    • International Business Machines Corporation
    • Medexter Healthcare
    • Perahealth Inc.
    • PointClickCare
    • Premier Inc.
    • Sunquest Information Systems Inc. (Roper Technologies Inc.)
Product Code: SR112024A4857

The global infection surveillance solutions market size reached US$ 652.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,314.8 Million by 2032, exhibiting a growth rate (CAGR) of 7.65% during 2024-2032. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on component, deployment type, and end user.

Breakup by Component:

Software

Services

Software represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the component. This includes software and services. According to the report, software represented the largest segment. The software is responsible for the collection, integration, analysis, and presentation of data related to healthcare-associated infections (HAIs) and infectious diseases. It plays a vital role in transforming raw patient data into actionable insights for healthcare providers. It comprises numerous functionalities, such as data integration, real-time monitoring, data analysis, reporting and visualization, and compliance and regulatory support. In line with this, the software enables healthcare organizations to proactively manage infections, improve patient safety, and enhance overall healthcare quality, which is contributing to the growth of the market.

Breakup by Deployment Type:

On-premises

Cloud-based

On-premises accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the deployment type. This includes on-premises and cloud-based. According to the report, on-premises represented the largest segment. On-premises refers to the installation and operation of infection surveillance solutions within the physical infrastructure of a healthcare facility or organization. In this deployment model, all software, hardware, and data storage are maintained locally on-site. On-premises solutions can be customized to meet the specific needs and workflows of the organization and allow for tailored infection surveillance processes. Apart from this, it offers low-latency access to information that allows for real-time monitoring and response to infection trends. Organizations often choose this deployment model when they prioritize data control, security, and compliance while accepting the responsibility of managing their IT infrastructure.

Breakup by End User:

Hospitals

Clinics

Ambulatory Service Centers

Specialty Centers

Others

Hospitals hold the biggest market share

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, ambulatory service centers, specialty centers, and others. According to the report, hospitals represented the largest segment. Hospitals are characterized by their high patient volumes, complex care environments, and the critical need for infection control. Moreover, hospitals prioritize patient safety, and infection surveillance is fundamental in achieving this goal. These solutions enable hospitals to monitor, detect, and prevent healthcare-associated infections (HAIs) promptly, thereby reducing patient morbidity and mortality. In addition, efficient infection control helps hospitals optimize resource allocation. By identifying infection trends and risk factors, hospitals can allocate resources effectively and ensure that critical care units and staff are available where needed most.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Baxter International Inc.

Becton Dickinson and Company

Centrak Inc. (Halma plc)

Cerner Corporation

CKM Healthcare Incorporated

Ecolab Inc.

International Business Machines Corporation

Medexter Healthcare

Perahealth Inc.

PointClickCare

Premier Inc.

Sunquest Information Systems Inc. (Roper Technologies Inc.)

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In January 2022, BD (Becton, Dickinson and Company), a leading global medical technology company, collaborated with Pfizer Inc. and global charitable foundation Wellcome to better understand the role of diagnostics in advancing antimicrobial stewardship practices around the world.

In 2021, Ecolab, the global leader in water, hygiene and infection prevention solutions and services, launched its Hand Hygiene Compliance Measurement (HHCM) System, a digitally connected technology to systematically monitor and improve hand hygiene in healthcare settings, across Europe.

In June 2022, Premier, Inc. announced that it is extending its technological capabilities to long-term care (LTC) facilities and providing the same level of clinical surveillance used in the acute setting.

Key Questions Answered in This Report

  • 1. What was the size of the global infection surveillance solutions market in 2023?
  • 2. What is the expected growth rate of the global infection surveillance solutions market during 2024-2032?
  • 3. What are the key factors driving the global infection surveillance solutions market?
  • 4. What has been the impact of COVID-19 on the global infection surveillance solutions market?
  • 5. What is the breakup of the global infection surveillance solutions market based on the component?
  • 6. What is the breakup of the global infection surveillance solutions market based on the deployment type?
  • 7. What is the breakup of the global infection surveillance solutions market based on the end user?
  • 8. What are the key regions in the global infection surveillance solutions market?
  • 9. Who are the key players/companies in the global infection surveillance solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Surveillance Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Deployment Type

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Service Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Specialty Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Centrak Inc. (Halma plc)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cerner Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 CKM Healthcare Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ecolab Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 International Business Machines Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medexter Healthcare
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perahealth Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 PointClickCare
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Premier Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sunquest Information Systems Inc. (Roper Technologies Inc.)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Infection Surveillance Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Infection Surveillance Solutions Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Infection Surveillance Solutions Market: Breakup by Deployment Type (in %), 2023
  • Figure 6: Global: Infection Surveillance Solutions Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Infection Surveillance Solutions Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Infection Surveillance Solutions (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Infection Surveillance Solutions (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Infection Surveillance Solutions (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Infection Surveillance Solutions (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Infection Surveillance Solutions (On-premises) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Infection Surveillance Solutions (On-premises) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Infection Surveillance Solutions (Cloud-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Infection Surveillance Solutions (Cloud-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Infection Surveillance Solutions (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Infection Surveillance Solutions (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Infection Surveillance Solutions (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Infection Surveillance Solutions (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Infection Surveillance Solutions (Ambulatory Service Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Infection Surveillance Solutions (Specialty Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Infection Surveillance Solutions (Specialty Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Infection Surveillance Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Infection Surveillance Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Infection Surveillance Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Infection Surveillance Solutions Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Infection Surveillance Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Infection Surveillance Solutions Industry: SWOT Analysis
  • Figure 76: Global: Infection Surveillance Solutions Industry: Value Chain Analysis
  • Figure 77: Global: Infection Surveillance Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Surveillance Solutions Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Infection Surveillance Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Infection Surveillance Solutions Market Forecast: Breakup by Deployment Type (in Million US$), 2024-2032
  • Table 4: Global: Infection Surveillance Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Infection Surveillance Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Infection Surveillance Solutions Market: Competitive Structure
  • Table 7: Global: Infection Surveillance Solutions Market: Key Players